 |
 |
We are seeking an independent statistician to join our Study Steering Committee for a six site feasibility cluster RCT. Trial Details Title: PREVENTion and Treatment of Incontinence Associated Dermatitis (IAD) through optimising care: development of the IAD Manual (PREVENT-IAD) Chief Investigator: Dr Sue Woodward Funder: NIHR - HTA Sponsor: King’s College London Supported by King’s Clinical Trials unit The study will run over 24 months. Meetings may be held remotely via teleconference or in person depending on your availability. We anticipate 3 meetings over the 2 year period (one in year one and two in year two). Travel expenses will be reimbursed. The overarching research aim is to assess the feasibility of developing and testing the feasibility of a manualised package of care to prevent and treat incontinence associated dermatitis in community settings. The study will take place over three phases: 1. Develop & manualise an optimal care package for the prevention & treatment of IAD (IAD Manual) within care homes & by care agencies, including a training, implementation & dissemination plan. (Year 1) 2. Design a future trial of the clinical & cost-effectiveness of the IAD Manual (Year 1) 3. Conduct a feasibility cluster randomised controlled trial (RCT) of the IAD Manual (Year 2). See study synopsis below. We are looking for involvement in the oversight committee to start from 1st March 2020. Please send queries, expressions of interest with CV to [log in to unmask]<mailto:[log in to unmask]> before 16th February 2020. Study Synopsis: Study Title PREVENTion and treatment of Incontinence-Associated Dermatitis (IAD) through optimising care: development and feasibility of the IAD Manual (PREVENT-IAD) NIHR Study No. HTA NIHR128865 Type of study Cluster randomised intervention feasibility study Trial Design Intervention co-design followed by 6 site feasibility cluster RCT Trial Participants Planned Sample Size 288 participants, 144 in each arm Follow-up duration 6 months from implementation of the IAD Manual in care homes/home care agencies Planned Trial Period 24 months in total, 0-12 months intervention development and 12-24 months intervention feasibility testing Research Aim to develop and assess the feasibility of a manualised package of care to prevent/treat IAD in community settings The overarching research aim is to assess the feasibility of developing and testing the feasibility of a manualised package of care to prevent and treat incontinence associated dermatitis in community settings. The study will take place over three phases: 1. Develop & manualise an optimal care package for the prevention & treatment of IAD (IAD Manual) within care homes & by care agencies, including a training, implementation & dissemination plan. (Year 1) 2. Design a future trial of the clinical & cost-effectiveness of the IAD Manual (Year 1) 3. Conduct a feasibility cluster randomised controlled trial (RCT) of the IAD Manual (Year 2). Primary Objectives To develop and assess the feasibility of the IAD Manual Primary outcome Change in core outcome set for IAD (IAD severity, IAD pain, resident satisfaction) compared to those receiving standard care over the same period. Secondary Objectives To assess feasibility outcomes: 1. Recruitment rates (cluster and individual) 2. Acceptability of intervention and study design for patients/residents/family members and staff (qualitative) 3. Attrition - attrition is a common issue affecting studies in care homes due to study withdrawal, high mortality, comorbidity, hospitalisation and transfers to another facility 4. Intervention fidelity (assessed through observation and review of documentation) To assess the experience of the implementation of the IAD Manual for residents and staff through qualitative interviews. Interventions Standard care: Standard care and standard treatment to prevent/treat IAD Intervention arm: 6 months care guided by IAD Manual ######################################################################## To unsubscribe from the STAT-LINK list, click the following link: https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=STAT-LINK&A=1